Dirk Loeffert – CEO
Dirk is co-founder of BIOMILLENIA and a senior executive of the Life Sciences industry with more than 20 years of experience in product development and commercialisation. After obtaining his Ph.D. in molecular genetics and immunology from the University of Cologne, Dirk joined QIAGEN where he was instrumental in building several new product portfolios at QIAGEN, such as QIAGENs enzyme and assay product portfolios. He represented in his former function at QIAGEN global product development as VP, Global Head of Product Development Life Sciences. In 2014, Dirk moved to Paris, France where he co-founded with scientific founders Dave Weitz (Harvard University, Cambridge), Rob Nicol (BROAD Institute, Cambridge) and Andrew Griffiths and Jerome Bibette (both ESPCI Paris, France) BIOMILLENIA.